Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml.
Hong ZengYuntian ChenJinge ZhaoJindong DaiYandong XieMinghao WangQian WangNanwei XuJunru ChenGuangxi SunHao ZengPeng-Fei ShenPublished in: World journal of urology (2024)
The developed nomogram has favorable predictive capability and clinical utility can help identify non-PCa to support clinical decision-making and reduce unnecessary prostate biopsies.